Bipolar mania and capacity to consent: Recommendations for investigators and IRBs

IRB Ethics and Human Research

Volumn 32, Issue 1, 2010, Pages 7-15

  Misra, Sahana ^a   Rosenstein, Donald ^b   Ganzini, Linda ^c   Socherman, Robert ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIPOLAR DISORDER; DECISION MAKING; DOCTOR PATIENT RELATION; ETHICS; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; MENTAL CAPACITY; PSYCHOLOGICAL ASPECT; UNITED STATES;

BIOMEDICAL RESEARCH; BIPOLAR DISORDER; DECISION MAKING; HUMANS; INFORMED CONSENT; MENTAL COMPETENCY; PHYSICIAN-PATIENT RELATIONS; UNITED STATES;

EID: 76749118002     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. National Bioethics Advisory Commission. Research Involving Persons with Mental Disorders That May Affect Decision Making Capacity, Vol.I. Washington, DC: National Bioethics Advisory Commission, 1998.
2. Appelbaum PS, Grisso T. Assessing patients' capacities to consent to treatment. NEJM 1998; 319: 1635-1638.
3. Appelbaum PS, Grisso T. MacArthur Competence Assessment Tool for Clinical Research. Sarasota, FL: Professional Resource Press, 2001;
4. Dunn LB, Nowrangi MA, Palmer BW, et al. Assessing decisional capacity for clinical research or treatment: A review of instruments. American Journal of Psychiatry 2006; 163: 1323-1334.
5. Carpenter WT, Gold JM, Lahti AC, et al. Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry 2000; 57: 533-538;
6. Stroup S, Appelbaum P, Swartz M, et al. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophrenia Research 2005; 80: 1-8.
7. See ref. 4, Carpenter et al. 1998;
8. Wirshing DA, Wirshing WC, Marder SR, et al. Informed consent: Assessment of comprehension. American Journal of Psychiatry 1998; 155: 1508-1511;
9. Stiles PG, Poythress NG, Hall A, et al. Improving understanding of research consent disclosures among persons with mental illness. Psychiatric Services 2001; 552: 780-785;
10. Dunn, LB, Lindamer LA, Palmer BW, et al. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry 2002; 10: 142-150.
11. Appelbaum PS, Roth LH, Lidz CW, et al. False hopes and best data: Consent to research and the therapeutic misconception. Hastings Center Report 1987; 17: 20-24;
12. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: Frequency and risk factors. IRB: Ethics & Human Research 2004; 26: 1-8.
13. Horng S, Grady C. Misunderstanding in clinical research: Distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. IRB: Ethics & Human Research 2003; 25: 11-16.
14. Henderson GE, Churchhill LR, Davis AM, et al. Clinical trials and medical care: Defining the therapeutic misconception. PLoS Medicine 2007; 4: e324.
15. Dunn LB, Palmer BW, Keehan M, et al. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. American Journal of Psychiatry 2006; 163: 500-506;
16. see ref. 6, Appelbaum et al. 2004.
17. See ref. 1, National Bioethics Advisory Commission 1998.
18. Kim SY, Kim HM, McCallum C, et al. What do people at risk for Alzheimer disease think about surrogate consent for research? Neurology 2005; 65: 1395-1401.
19. Stroup TS, Appelbaum PS. Evaluation of "subject advocate" procedures in the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia study. Schizophrenia Bulletin 2006; 32: 147-152.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Health Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.
21. Yen CF, Chen CS, Yeh ML, et al. Changes of insight in manic episodes and influencing factors. Comprehensive Psychiatry 2003; 44: 404-408;
22. Dell'Osso L, Pini S, Cassano GB, et al. Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. Bipolar Disorders 2002; 4: 315-322;
23. Murphy FC, Rubinsztein JS, Michael A, et al. Decision-making cognition in mania and depression. Psychological Medicine 2001; 31: 679-693;
24. Rubinsztein JS, Fletcher PC, Rogers RD, et al. Decision-making in mania: PET study. Brain 2001; 124: 2550-2563.
25. See ref. 2, Appelbaum et al. 1998.
26. Janicak PG, Davis JM, Preskorn SH, et al. Principles and Practice of Psychopharmacotherapy, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006.
27. Gitlin MJ, Swendsen J, Heller TL, et al. Relapse and impairment in bipolar disorder. American Journal of Psychiatry 1995; 152: 1635-1640.
28. See ref. 14, Yen et al. 2003;
29. Yen CF, Chen CS, Yeh ML, et al. Correlates of insight among patients with bipolar I disorder in remission. Journal of Affective Disorders 2004; 78: 57-60;
30. Rubinsztein JS, Michael A, Paykel ES, et al. Cognitive impairment in remission in bipolar affective disorder. Psychological Medicine 2000; 30: 1025-1036.
31. Palmer BW, Dunn LB, Depp CA, et al. Decisional capacity to consent to research among patients with bipolar disorder: Comparison with schizophrenia subjects and healthy subjects. Journal of Clinical Psychiatry 2007; 68: 689-696.
32. Misra S, Socherman R, Park BS, et al. Influence of mood state on capacity to consent to research in patients with bipolar disorder. Bipolar Disorders 2008a; 10: 303-309;
33. Misra S, Socherman R, Hauser P, et al. Appreciation of research information in patients with bipolar disorder. Bipolar Disorders 2008b; 10: 635-646.
34. See ref. 20, Misra et al. 2008a;
35. see ref. 20, Misra et al. 2008b.
36. See ref. 20, Misra et al. 2008a.
37. See ref. 20, Misra et al. 2008b.
38. See ref. 20, Misra et al. 2008b.
39. See ref. 20, Misra et al. 2008a.
40. See ref. 20, Misra et al. 2008b.
41. See ref. 20, Misra et al. 2008b.
42. Kim SY, Kim HM, Langa KM, et al. Surrogate consent for dementia research: A national survey of older Americans. Neurology 2009; 72: 149-155.
43. See ref. 3, Dunn et al. 2006.
44. See ref. 20, Misra et al. 2008a.
45. See ref. 5, Wirshing et al. 1998;
46. see ref. 5, Stiles et al. 2001;
47. see ref. 5, Dunn et al. 2002.
48. See ref. 1, National Bioethics Advisory Commission 1998.
49. See ref. 1, National Bioethics Advisory Commission 1998.
50. Muthappan P, Forster H, Wendler D. Research advanced directives: Protection or obstacle? American Journal of Psychiatry 2005; 162: 2389-2391.
51. See ref. 20, Misra et al. 2008b.